[Federal Register Volume 72, Number 2 (Thursday, January 4, 2007)]
[Notices]
[Pages 346-347]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-9970]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases, Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Cooperative Research Patnerships 
for Influenza Product Development.
    Date: January 24-25, 2007.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Silver Spring, 8727 Colesville Road, Silver 
Spring, MD 20910.

[[Page 347]]

    Contact Person: Clayton C. Huntley, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIAID/NIH/DHHS, Room 3246, 6700B Rockledge Drive, MSC 
7616, Bethesda, MD 20892-7616, (301) 451-2570 <a href="/cdn-cgi/l/email-protection#33505b07030647735d5a5b1d545c45"><span class="__cf_email__" data-cfemail="30535804000544705e59581e575f46">[email protected]</span></a>.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Study of Antigen Presentation 
Unsolicited P01.
    Date: January 25, 2007.
    Time: 10 a.m. to 1 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Cheryl K. Lapham, PhD, Scientific Review 
Administrator, Scientific Review Program, National Institute of 
Allergy and Infectious Diseases, DEA/NIH/DHHS, 6700-B Rockledge 
Drive, MSC 7616, Room 3127, Bethesda, MD 20892-7616, 301-402-4598, 
<a href="/cdn-cgi/l/email-protection#682b04091800090528060109010c46060100460f071e"><span class="__cf_email__" data-cfemail="e2a18e83928a838fa28c8b838b86cc8c8b8acc858d94">[email protected]</span></a>.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Cooperative Research Partnerships 
for Influenza Product Development.
    Date: January 29-30, 2007.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Silver Spring, 8727 Colesville Road, Silver 
Spring, MD 20910.
    Contact Person: Clayton C. Huntley, Phd, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIAID/NIH/DHHS, Room 3246, 6700B Rockledge Drive, MSC 
7616, Bethesda, MD 2089-7616, (301) 451-2570, <a href="/cdn-cgi/l/email-protection#9dfef5a9ada8e9ddf3f4f5b3faf2eb"><span class="__cf_email__" data-cfemail="98fbf0aca8adecd8f6f1f0b6fff7ee">[email protected]</span></a>.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Study of Immunoregulation 
Unsolicited P01.
    Date: February 7, 2007.
    Time: 12 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge 6700, 6700B 
Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Cheryl K. Lapham, PhD, Scientific Review 
Administrator, Scientific Review Program, National Institute of 
Allergy and Infectious Diseases, DEA/NIH/DHHS, 6700-B Rockledge 
Drive MSC 7616, Room 3127, Bethesda, MD 20892-7616, 301-402-4598, 
<a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="50333c312038313d103e393139347e3e39387e373f26">[email protected]</a>.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Safety Evaluation of Anti-Infective 
Agents.
    Date: February 12, 2007.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda North Marriot Hotel, 5701 Marinelli Road, North 
Bethesda, MD 20852.
    Contact Person: Quirijn Vos, PhD, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, National Institutes of Health/NIAID, 6700B Rockledge 
Drive, MSC 7616, Bethesda, MD 20892-7616, 301-496-2550, 
<a href="/cdn-cgi/l/email-protection#d9a8afb6aa99b7b0b8b0bdf7b7b0b1f7beb6af"><span class="__cf_email__" data-cfemail="e9989f869aa9878088808dc7878081c78e869f">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: December 26, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-9970 Filed 1-3-07; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>